Skip to main content

Revance will initially address one of the largest demands within the facial aesthetics category, glabellar (frown) lines.

Revance Clinical Program Update:

  • Product candidate DaxibotulinumtoxinA For Injection (DAXI) has been evaluated in a Phase 2 head-to-head, active comparator study (BELMONT), and in three Phase 3 trials (SAKURA), for the treatment of glabellar lines. The company plans to file for regulatory approval in the Fall of 2019 and potentially launch DAXI in 2020.

  • DAXI is also being studied for the treatment of forehead line and lateral canthal lines (crow's feet). Phase 2 trials are expected to be fully enrolled in the Summer of 2019 and have results in the first half of 2020. These studies will provide valuable dosing and injection site information on DAXI's potential use across the upper face.

For the latest information regarding our clinical development programs, please see our public filings with the Securities and Exchange Commissions, as well as the press releases we issue, or visit www.clinicaltrials.gov

Anti-Aging: Facts, Figures & Trends

  • Use of botulinum toxin products for aesthetic and therapeutic indications represents an estimated $4.5 billion market globally.
  • Botulinum toxin procedures continue to drive the nonsurgical aesthetic market and have remained the #1 nonsurgical procedure since 2000.
  • Botulinum toxin injections (aesthetic) have seen a 5,407% increase in number of procedures from 1997-2014.*
  • A recent quantitative study of 80 community dermatologists and cosmetic surgeons revealed that DAXI, if approved, would address an unmet need by offering a longer duration of effect. This same group voiced a significant likelihood to use DAXI and make it their treatment of choice.**

* 2015 ASAPS Statistical data

** Revance. Data on file.

Glabellar Lines

The glabella is the skin that sits between the eyebrows and above the nose.

Facial wrinkling is promoted by habitual facial expressions, aging, sun damage, smoking, poor hydration, and various other factors.

Aging theory suggests that wrinkles develop from incorrect repairs of injured elastic fibers and collagen fibers. Repeated extensions and compressions of the skin cause repeated injuries of extracellular fibers in derma. During the repairing process, some of the broken elastic fibers and collagen fibers are not regenerated and restored, but replaced by altered fibers.

Botulinum toxin treats glabellar (frown) lines by immobilizing the muscles that cause wrinkles.

Facts, Figures & Trends

  • Deep muscles like those that form the glabellar (frown) lines may be best served by an injectable formulation like DAXI.

Presentations & Publications